BOSTON SCIENTIFIC CORP (BSX) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-03

Key Insights

Insider Emily Woodworth, SVP and Global Controller, exercised 838 restricted stock units and sold 372 shares of Boston Scientific common stock on March 1, 2026.
The transaction resulted in Woodworth directly owning 2,859 shares of Boston Scientific, down from 3,231 shares prior to the transaction.
Insiders' transactions can provide signals about a company's future prospects, and should be monitored by investors.

Want the newest filings?

This analysis covers the filing from 2026-03-03. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-02-27

The reporting person, Arthur C. Butcher, who is an EVP & Grp Pres at Boston Scientific Corp, acquired 6,851 shares of common stock through the company's 401(k) Retirement Savings Plan, indicating their confidence in the company's performance.
The reporting person still holds a significant direct ownership of 55,792 shares, suggesting they remain invested in the long-term success of Boston Scientific Corp.
The acquisition of shares through the 401(k) plan indicates the reporting person's commitment to the company and their belief in its growth potential.

Filed: 2026-02-03

Insider Michael F. Mahoney, the Chairman, President and CEO of Boston Scientific, has reported multiple transactions, including exercising stock options and selling shares.
The transactions were made pursuant to a pre-established Rule 10b5-1 trading plan, suggesting planned and routine portfolio management rather than a reaction to specific events.
The reported transactions do not indicate any major changes or shifts in Mahoney's ownership or leadership position, maintaining his role as a key insider and significant shareholder.

Other reports for BOSTON SCIENTIFIC CORP

Current Report Quarterly Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.